PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8640957-2	1996	The oxidation effect of methylglyoxal significantly potentiated by thrombin, depends on both the ketoaldehyde and the agonist concentrations.	Pyruvaldehyde	24-37	coagulation factor II, thrombin	Homo sapiens	67-75	
8640957-6	1996	Methylglyoxal inhibits platelet aggregation induced by several agonists and ATP release induced by thrombin.	Pyruvaldehyde	0-13	coagulation factor II, thrombin	Homo sapiens	99-107	
8288025-8	1993	A further significant increase was observed in platelets stimulated with thrombin in the presence of methylglyoxal.	Pyruvaldehyde	101-114	coagulation factor II, thrombin	Homo sapiens	73-81	
25307422-5	2014	METHODS: MGO-mediated ATIII inhibition was confirmed using inverse experiments detecting activity of the ATIII targets thrombin and factor Xa.	Pyruvaldehyde	9-12	coagulation factor II, thrombin	Homo sapiens	119-127	
25307422-8	2014	RESULTS AND CONCLUSIONS: MGO concentration-dependently attenuated inhibition of thrombin and factor Xa by ATIII in PBS-based assays, both in the presence and absence of heparin.	Pyruvaldehyde	25-28	coagulation factor II, thrombin	Homo sapiens	80-88